N

New England Cancer Specialists | Topsham, ME

Research site

(Unclaimed)

Location

105 Topsham Fair Mall Road Suite 1, Topsham, Maine, United States of America

Site insights

Top conditions

Top treatments

Sunitinib

Androgen

Avelumab

Axitinib

PF-06821497

Enfortumab

Abiraterone Acetate

Mevrometostat

Parent organization

This site is a part of New England Cancer Specialists

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 4 total trials

A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

This is a randomized, open-label, three-arm, phase 3 study in men with biochemically recurrent prostate cancer and PSA doubling time ≤ 9 months at th...

Active, not recruiting

Prostate Cancer

Drug: LHRH Analogue

Drug: Prednisone

Locations recently updated

A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).

Pfizer MEVPRO-1 (C2321014) is a randomized, open-label, multi-center clinical trial evaluating whether combining the study medicine (PF-06821497) wit...

Enrolling

Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Drug: PF-06821497

Drug: Enzalutamide

Trial sponsors

A

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms